Actinobacillus actinomycetemcomitans suppresses rat natural killer cell activity in vivo

Acta Oto-Laryngologica

Volumn 124, Issue 5, 2004, Pages 621-627

  Ghoneum, Mamdooh ^a   Saglie, Reinaldo ^b   Brown, Jimmy ^a   Regala, Christopher ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacterial infection; Immune suppression; Lymphocytes

Indexed keywords

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; CYTOLYSIS; DATA ANALYSIS; FEMALE; IN VIVO STUDY; NATURAL KILLER CELL; NONHUMAN; NORMAL VALUE; PRIORITY JOURNAL; RAT; SPLEEN LYMPHOCYTE; STATISTICAL SIGNIFICANCE; SUPPRESSOR CELL; T LYMPHOCYTE; TARGET CELL; TUMOR CELL;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; FEMALE; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; LYMPHOCYTES; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN;

EID: 3042698781     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310015759     Document Type: Article

References (35)

1. Christersson LA, Albuni B, Zambon J, Slots J, Genco RJ. Demonstration of Actinobacillus actinomycetemcomitans in gingiva of localized juvenile periodontitis lesions [Abstract]. J Dent Res 1983; 62: 198.
2. Tan KS, Song KP, Ong G. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J Periodontal Res 2002; 37: 268-72.
3. Saglie FR, Carranza Jr FA, Newman MG, Cheng L, Lewing KJ. Identification of tissue invading bacteria in human periodontal disease. J Periodontal Res 1982; 17: 452.
4. Saglie FR, Smith CT, Newman MG, et al. The presence of bacteria in the oral epithelium in periodontal disease. II. Immunohistochemical identification of bacteria. J Periodontol 1986; 57: 492-500.
5. Saglie RF, Pertuiset JH, Rozende MT, Sabet MS, Raoufi D, Carranza FA. Bacterial invasion in experimental gingivitis in man. J Periodontol 1987; 58: 837.
6. Genco RJ, Slots J. Host responses in periodontal disease. J Dent Res 1984; 63: 441-51.
7. Slots J, Genco RJ. Black pigmented bacteriodes species, capnocytophaga species and actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival and tissue destruction. J Dent Res 1984; 63: 412-21.
8. Taichman NS, Dean RT, Sanderson CJ. Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 1980; 28: 258-68.
9. VanDeusen JB, Caligiuri MA. New developments in anti-tumor efficacy and malignant transformation of human natural killer cells. Curr Opin Hematol 2003; 10: 55-9.
10. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131: 1531-8.
11. Vankayalapati R, Wizel B, Weis SE, et al. The KNp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2002; 168: 3451-7.
12. Saglie FR, Pertuiset J, Rozende MT, Nestor M, Marfany A, Carranza FA. In situ correlative immunoidentification of mononuclear infiltrates and invasive bacteria in diseased gingiva. J Periodontol 1988; 59: 688-96.
13. Timonen T, Ortaldo JR, Heberman RB. Characterization of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 1981; 153: 569-82.
14. Grimm E, Bonavida B. Mechanism of cell-mediated cytotoxicity at a single cell level. 1. Estimation of cytotoxic T-lymphocyte frequency and relative lytic efficiency. J Immun 1979; 123: 2861-9.
15. Nencioni L, Villa L, Boraschi B, Tagilabue A. Modulation of in vitro natural cell-mediated activity against enteropathogenic bacteria by simple sugars. Infect Immun 1985; 47: 534-9.
16. Nabavi N, Murphy J. In vitro binding of natural killer cells to cryptococcus neoformans targets. Infect Immun 1985; 50: 50-7.
17. Godshall CJ, Scott MJ, Burch PT, Peyton JC, Cheadle WG. Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock 2003; 19: 144-9.
18. Holmberg LA, Springer TA, Adult KA. Natural killer activity in the peritoneal exudates of mice infected with Listeria monocytogenes: characterization of the natural killer cells by using a monoclonal rat anti-murine macrophage antibody (M1/70). J Immunol 1981; 127: 1792-9.
19. Kumpel GR, Niesel DW, Klimpel KD. Natural cytotoxic effector cell activity against Shigella flexneri-infected hela cells. J Immunol 1986; 136: 1081-6.
20. Kirby AC, Yrlid U, Wick MJ. The innate immune response differs in primary and secondary Salmonella infection. J Immunol 2002; 169: 4450-9.
21. Chackerian A, Alt J, Perera V, Behar SM. Activation of NKT cells protects mice from tuberculosis. Infect Immun 2002; 70: 6302-9.
22. Badgwell B, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE 3rd. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 2002; 132: 205-12.
23. Danelishvilli L, Bermudez LE. Role of type I cytokines in host defense against Mycobacterium avium infection. Curr Pharm Des 2003; 9: 61-5.
24. Robinson K, Neal KR, Howard C, et al. Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect Immun 2002; 70: 1301-9.
25. Zoller M, Matzku S, Andrighetto G, Wigzell H. Regulation of NK reactivity by suppressor cells in NK cells and other natural effector cells. RB Herberman, ed.. New York: Academic Press; 1982. p. 541-8.
26. Holub M, Kluckova Z, Beneda B, et al. Changes in lymphocyte subpopulations and CD3+/DR4- expression in sepsis. Clin Microbiol Infect 2000; 6: 657-60.
27. Holub M, Kluckova Z, Helcl M, Prihodov J, Rokyta R, Beran O. Lymphocyte subset numbers depend on the bacterial origin of sepsis. Clin Microbiol Infect 2003; 9: 202-11.
28. Johansson A, Claesson R, Belibasakis G, et al. Lack of lipoprotein-dependent effects on the cytotoxic interactions of Actinobacillus actinomycetemcomitans leukotoxin with human neutrophils. APMIS 2002; 110: 857-62.
29. Johansson A, Claesson R, Hanstrom L, Kalfas S. Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans. Eur J Oral Sci 2003; 111: 209-15.
30. Shenker BJ, Vitale LA, Keiba I, et al. Flow cytometric analysis of the cytotoxic effects of Actinobacillus actinomycetemcomitans leukotoxin on human natural killer cells. J Leukoc Biol 1994; 55: 153-60.
31. Lindemann RA. Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharide. Infect Immun 1988; 56: 1301-8.
32. Lindemann RA, Eilber R. Activation of human natural killer cells by lipopolysaccharide from Actinobacillus actinomycetemcomitans. Arch Oral Biol 1989; 34: 459-63.
33. Tran P, Ahmad R, Xu J, Ahmad A, Menezes J. Host's innate immune response to fungal and bacterial agents in vitro: up-regulation of interleukin-15 gene expression resulting in enhanced natural killer cell activity. Immunology 2003; 109: 263-70.
34. Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 2000; 68: 752-9.
35. Haller D, Serrant P, Granato D, Schiffrin EJ, Blum S. Activation of human NK cells by staphylococci and lactobacilli requires cell contact dependent costimulation by autologous monocytes. Clin Diagn Lab Immunol 2002; 9: 649-57.